Stopping immunomodulators and biologics in inflammatory bowel disease patients in remission

Maintenance of clinical benefit in Crohn’s disease patients after discontinuation of infliximab: long-term follow-up of a single centre cohort

(2010) A. W. G. Waugh et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Predictors of Infliximab Failure After Azathioprine Withdrawal in Crohn's Disease Treated With Combination Therapy

(2010) Abderrahim Oussalah et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study

(2010) Y. Tanaka et al.   ANNALS OF THE RHEUMATIC DISEASES

Maintenance Treatment With Azathioprine in Ulcerative Colitis: Outcome and Predictive Factors After Drug Withdrawal

(2009) Andrea Cassinotti et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Azathioprine Withdrawal in Patients With Crohn's Disease Maintained on Prolonged Remission: A High Risk of Relapse

(2008) Xavier Treton et al.   Clinical Gastroenterology and Hepatology

Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort

(2008) F Schnitzler et al.   GUT

Discontinuation of infliximab in rheumatoid arthritis patients in clinical remission

(2008) Masao Nawata et al.   Modern Rheumatology